Navigation Links
World Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals)
Date:2/6/2012

NEW YORK, Feb. 6, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

World Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals)

http://www.reportlinker.com/p0769020/World-Market-for-Anti-Infectives-Antifungals-Antibacterials-and-Antivirals- .html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

This Kalorama Information report – The World Market for Anti-Infectives - focuses on three key segments of treatment:

  • Antifungals (Allylamines, Azoles, Polyene Macrolides, Other Antifungals)
  • Antibacterials (Aminoglycosides, Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones, Sulfonamides, Tetracyclines, Others)
  • Antivirals (Nucleoside Analogs, Transcriptase Inhibitors, DNA Polymerase Inhibitors, Protease Inhibitors, Other Antivirals)

The report covers both currently marketed and late stage development products. Revenues for each segment were generated using dollar and unit sales for each product.

A novel approach of this report is it provides revenue

by product type

but also the 'market' for treatments

by type of infection

, enabling the marketer to research the best markets where a variety of products may be implemented.

The report includes statistical information for infections by type worldwide, with special emphasis on the U.S. and Europe. The market segments provide an overview, description of products on the market, description of product
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Henry Scheins Chairman and CEO Addresses the World Economic Forum
2. Worlds Leading Pharmaceutical Executives All Converging in Zurich, Switzerland on February 21-22, 2012 for Breakthrough Event
3. China Health Resource Announces Professor Liang Li, World Renowned TCM Expert, to Lead Gastrodia Deep Processing Research
4. Cardica Achieves Key Milestone With Over 25,000 PAS-Port® Proximal Anastomosis Systems Deployed Worldwide
5. Boston IVF Pioneers Worlds First Needle-Free Saliva Test Used in Infertility Treatment; Patient Friendly Monitoring Replaces Daily Blood Tests
6. UH Case Medical Center the First in Region to Enroll Patients in Worldwide Study
7. OncoSec to Present at World Cancer Immunotherapy Conference
8. World Micro Adds to Specialized Counterfeit Detection Equipment
9. World Market for Gastrointestinal Devices, The
10. Thermogenesis Signs Worldwide Res-Q System Distribution Agreement With Arthrex for Sports Medicine Applications
11. The Outlook for Medical Devices Worldwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2012)...  Avaxia Biologics, Inc., a privately-held biotechnology ... locally within the gastrointestinal tract, announced today ... 8,182,818, entitled "Methods of Using Anti-TNF Antibodies ... Tract." This patent provides broad ... to treat radiation induced damage to the ...
(Date:5/22/2012)...  Upsher-Smith Laboratories, Inc. announced today that Senior ... McKesson Branded Pharmaceutical Representative of the Year Award ... Las Vegas, NV on May 8, 2012.  The ... President of Purchasing at McKesson.  ... CA-based McKesson, one of the largest pharmaceutical distributors ...
(Date:5/22/2012)... -- APEX BIOSTRATEGISTS, A FULL SERVICE ADVISORY FIRM, LED ... SALE BY NPE SYSTEMS, INC. AND BLUE OCEAN BIOMEDICAL, ... NPE AND BLUE OCEAN WERE TECHNOLOGY LEADERS IN THE ... TISSUE TESTING FOR PATIENT MONITORING AND FOR DRUG RESEARCH. ... OF FLOW CYTOMETRY SYSTEMS TO HOSPITALS AND TESTING LABS ...
Breaking Medicine Technology:Avaxia Biologics is Awarded U.S. Patent for Method to Treat Radiation Damage to the Digestive Tract and Mucositis Caused by Radiation 2Dave Zitnak Of Upsher-Smith Laboratories Named Branded Representative Of The Year By McKesson Corporation 2Apex BioStrategists Advises On Flow Cytometry Sale To Coulter 2Cedars Sinai awarded 241 9 million from CIRM to develop stem cell treatments for osteoporosis 76539 1Cedars Sinai awarded 241 9 million from CIRM to develop stem cell treatments for osteoporosis 76539 2Medivir Interim Report 1 January 30 September 2010 12006 1Medivir Interim Report 1 January 30 September 2010 12006 2Medivir Interim Report 1 January 30 September 2010 12006 3Medivir Interim Report 1 January 30 September 2010 12006 4Medivir Interim Report 1 January 30 September 2010 12006 5Medivir Interim Report 1 January 30 September 2010 12006 6Medivir Interim Report 1 January 30 September 2010 12006 7Medivir Interim Report 1 January 30 September 2010 12006 8Essilor Third Quarter 2010 Report 12004 1Essilor Third Quarter 2010 Report 12004 2Essilor Third Quarter 2010 Report 12004 3Essilor Third Quarter 2010 Report 12004 4Essilor Third Quarter 2010 Report 12004 5Essilor Third Quarter 2010 Report 12004 6Essilor Third Quarter 2010 Report 12004 7Essilor Third Quarter 2010 Report 12004 8Essilor Third Quarter 2010 Report 12004 9Essilor Third Quarter 2010 Report 12004 10
... Nektar,Therapeutics (Nasdaq: NKTR ) today ... study,for NKTR-118 (PEG-naloxol), an oral treatment being ... clinical manifestations of,opioid-induced bowel dysfunction (OBD). The ... safety and tolerability,of NKTR-118 in patients experiencing ...
... Data and Emerging Clinical Practice Experience Support ... HYLENEX Efficacy and ... Inc.,(Nasdaq: HALO ), a biopharmaceutical company developing and commercializing,products ... of the INFUSE-LR clinical trial results in the Journal,of Palliative ...
Other Medicine Technology:Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction 2Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction 3Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction 4Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction 5Halozyme Therapeutics Announces Peer-Reviewed Publications of the INFUSE-LR Clinical Trial Results and Clinical Practice Experience With Hylenex 2Halozyme Therapeutics Announces Peer-Reviewed Publications of the INFUSE-LR Clinical Trial Results and Clinical Practice Experience With Hylenex 3Halozyme Therapeutics Announces Peer-Reviewed Publications of the INFUSE-LR Clinical Trial Results and Clinical Practice Experience With Hylenex 4Halozyme Therapeutics Announces Peer-Reviewed Publications of the INFUSE-LR Clinical Trial Results and Clinical Practice Experience With Hylenex 5
(Date:5/23/2012)... research suggests that young asthma patients who use drugs ... -- could be more likely than others to suffer ... increased risk was not seen for some types of ... the recent interest in use of anticholinergics in asthma," ... at Chicago, said in a news release from the ...
(Date:5/23/2012)... treatment with inhaled corticosteroids in patients with respiratory ... associated with a lower incidence and severity of ... researchers in Spain. , A parapneumonic effusion is ... accumulates between the two pleural layers, the fluid-filled ... a result of a pneumonia, lung abscess, or ...
(Date:5/22/2012)... Ill. Magnetic resonance imaging (MRI) provides an ... chemotherapy significantly earlier than possible through clinical examination, ... the journal Radiology . , Women ... surgery. Research has shown that women who receive ... likely to achieve breast conservation than those receiving ...
(Date:5/22/2012)... HealthDay Reporter , , TUESDAY, May 22 (HealthDay News) -- ... common cause of snoring and daytime sleepiness, might also ... the condition -- the risk of developing high blood ... new cases of high blood pressure in two groups ... therapy, or CPAP, for either about four or 11 ...
(Date:5/22/2012)... 22, 2012) -- Researchers at Barrow Neurological Institute ... unveiled how and why the public perceives some ... real-world implications in military tactics, marketing and sports. ... Visual Neuroscience, and Stephen Macknik, PhD, of Barrow,s ... their research into magic and illusions. Their most ...
Breaking Medicine News(10 mins):Health News:Asthma Meds May Be Linked to Irregular Heartbeat 2Health News:Long-term ICS use reduces pleural effusion in patients with CAP 2Health News:Breast MRI helps predict chemotherapy's effectiveness 2Health News:Sleep Apnea 'Mask' Might Also Help the Heart 2Health News:Sleep Apnea 'Mask' Might Also Help the Heart 3Health News:Sleep Apnea 'Mask' Might Also Help the Heart 4Health News:Barrow researchers use magic for discoveries 2
... planning to recruit 50,000 people as a part of a large ... relationship // between lifestyle and genetics as regards the health of ... two decades and is one of the largest healthcare projects in ... large pool of information so that it would be easy to ...
... Life of Life Healing Spa is increasingly getting more customers ... the very first session. // Owner Karen Chu claims that ... degree of success since the spa first began offering the ... given here has not yet resulted in any injuries. Most ...
... after eating a single sweet as she suffered from nut ... cream cake but had // failed to identify the chocolate-covered ... and lost consciousness in an hour’s time. She was immediately ... causing irreversible brain damage. , ,Five days later, ...
... and cancer drugs which it hopes will increase its sales ... starting // to market two of its new diabetes drug ... treating type 2 diabetes. ,The drug Avandaryl is ... the drug Avandamet is produced by the combination of Avandina ...
... countrymen safe drinking water within a matter of four ... // to make this possible. Most people living in ... water. ,Inaugurating a conference of ministers ... sanitation in states and union territories, the prime minister ...
... per a study in Tanzania by Duke University Medical Centre, it ... cost effective than charging a small fee for them. // ... free test rather than a charged test. ,The statistics ... a two-week pilot program in 2003. ,The numbers which ...
Other Medicine News:Health News:Safe Drinking Water To Be Made Available 2Health News:Free HIV Tests far more cost effective than small fee 2
... CryoCath has developed a minimally ... reentrant tachycardia. It delivers a very ... site confirmation, pinpoint site precision, minimal ... thrombus and stenosis., ,Freezor Xtra allows ...
... CryoCath has developed a minimally invasive ... tachycardia. It delivers a very high ... confirmation, pinpoint site precision, minimal tissue ... and stenosis., ,Freezor is a flexible, ...
The Medtronic CardioRhythm Marinr Catheter is intended for use in diagnostic electrophysiologic procedures. These catheters are designed for recording intracardiac electrograms and temporary pacing a...
Ten-Ten duodecapolar diagnostic mapping catheters are available in four curve sizes....
Medicine Products: